|
An Open-Label, Randomized, Phase 2 To Assess The Effectiveness Of RCHOP With Or Without VELCADE In Previously Untreated Patients With Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma
|
There are two main categories of DLBCL- 1) germinal center (GC) type and 2) non-GC type. The standard treatment for both types of DLBCL is a combination of drugs called RCHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone). Unfortunately, RCHOP works less well in patients with non-GC DLBCL. However, a better treatment than RCHOP for patients with non-GC DLBCL is not currently known.
|
Principal Investigator(s):
Tarun Kewalramani, MD
For more information about this Research Study call 781-744-8027.
Study Coordinator(s):
Deborah J. Gannon,
Nancy M. Campbell, RN.
|